Why Was the Study Undertaken? ∘ The study aimed to characterise juvenile‐onset mycosis fungoides (JMF), a rare and under‐ recognised cutaneous T‐cell lymphoma. The researchers analysed the clinical, histopathological, and immunophenotypic features; treatment response; and long‐term outcomes of a multicenter Italian cohort. They paid particular attention to age‐ related differences. • What Does This Study Add? ∘ It is one of the largest Southern European JMF cohorts with extended follow‐up. The study confirms the high prevalence of CD8⁺ phenotypes and hypopigmented variants, highlights a frequent association of JMF with atopic dermatitis in younger children, and identifies a possible age‐related gradient in long‐term remission rates. • What Are the Implications of This Study for Understanding the Disease and/or Providing Clinical Care? ∘ The findings support recognising JMF as a clinically and biologically distinct entity. Earlier onset of the disease may predict more sustained remission, which underscores the need for paediatric‐specific diagnostic vigilance and management guidelines
Juvenile Mycosis Fungoides: A Multicenter Retrospective Italian Study
Michelerio, Andrea;Svizzero, Alessandro;Brazzelli, Valeria
2026-01-01
Abstract
Why Was the Study Undertaken? ∘ The study aimed to characterise juvenile‐onset mycosis fungoides (JMF), a rare and under‐ recognised cutaneous T‐cell lymphoma. The researchers analysed the clinical, histopathological, and immunophenotypic features; treatment response; and long‐term outcomes of a multicenter Italian cohort. They paid particular attention to age‐ related differences. • What Does This Study Add? ∘ It is one of the largest Southern European JMF cohorts with extended follow‐up. The study confirms the high prevalence of CD8⁺ phenotypes and hypopigmented variants, highlights a frequent association of JMF with atopic dermatitis in younger children, and identifies a possible age‐related gradient in long‐term remission rates. • What Are the Implications of This Study for Understanding the Disease and/or Providing Clinical Care? ∘ The findings support recognising JMF as a clinically and biologically distinct entity. Earlier onset of the disease may predict more sustained remission, which underscores the need for paediatric‐specific diagnostic vigilance and management guidelinesI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


